NEW YORK (GenomeWeb) – Selah Genomics, a wholly owned subsidiary of EKF Diagnostics, has inked an agreement with an unnamed US national sales organization to provide testing services for a new suite of assays focused on women's health. The organization has an established customer base of clinicians who use its panel of women's health tests, which will be run at Selah's CLIA-certified laboratory in Greenville, SC. The test menu is also being expanded to include the Roche cobas HPV Test. Financial and other terms of the agreement were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.